Vor Biopharma Inc. (VOR) Reports In-Line Q3 EPS

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($0.40), in-line with the analyst estimate of ($0.40).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
• Motorcar Parts of America (MPAA) Misses Q1 EPS by 90c ; Offers Guidance
• Bloomin' Brands (BLMN) PT Raised to $12 at Piper Sandler